OTC Drug Review’s Constitutionality Questioned By CHPA
This article was originally published in The Tan Sheet
Executive Summary
FDA's OTC Drug Review could be challenged on constitutional grounds, the Consumer Healthcare Products Association states in Sept. 13 comments to the agency
You may also be interested in...
Labeling Based On Consumer Comprehension Data Stressed By McClellan
Empirical data on consumer comprehension of food and drug labeling would play a prominent role in FDA rulemaking if the Senate confirms White House economic advisor Mark McClellan, MD/PhD, as the agency's new commissioner
Labeling Based On Consumer Comprehension Data Stressed By McClellan
Empirical data on consumer comprehension of food and drug labeling would play a prominent role in FDA rulemaking if the Senate confirms White House economic advisor Mark McClellan, MD/PhD, as the agency's new commissioner
Labeling Based On Consumer Comprehension Data Stressed By McClellan
Empirical data on consumer comprehension of food and drug labeling would play a prominent role in FDA rulemaking if the Senate confirms White House economic advisor Mark McClellan, MD/PhD, as the agency's new commissioner